An assessment of CD8 T cells after stimulation by mIL-12 or mIL12-FHAB was performed at 24- and 96-hours after dosing using confocal microscopy with tissue from the draining inguinal lymph node adjacent to the tumor implant (Figure 7). The gene discussed is CD8A; the disease is neoplasm.